References
- Ebinger JE, Fert-Bober J, Printsev I, Wu M, Sun N, Prostko JC, et al.
Antibody responses to
the BNT162b2 mRNA vaccine in individuals previously infected with
SARS-CoV-2. .Nat Med. 2021 Apr 1. doi: 10.1038/s41591-021-01325-6
- Krammer F., Srivastava K., the PARIS team, Simon V. Robust spike
antibody responses and increased reactogenicity in seropositive
individuals after a single dose of SARS-CoV-2 mRNA vaccine MedRxiv
[Preprint].2021a. doi.org/10.1101/2021.01.29.21250653
- Tré-Hardy M, Cupaiolo R, Papleux E, Wilmet A, Horeanga A,
Antoine-Moussiaux T, et al.
Reactogenicity,
safety and antibody response, after one and two doses of mRNA-1273 in
seronegative and seropositive healthcare workers. J Infect. 2021 Mar
31:S0163-4453(21)00158-4. doi: 10.1016/j.jinf.2021.03.025
- Prokop M.,
van
Everdingen W.,
van
Rees Vellinga T.,
Quarles
van Ufford, H.
Lauran
Stöger, Beenen
L., Geurts
B. CO-RADS: A Categorical CT Assessment Scheme for Patients
Suspected of Having COVID-19-Definition and Evaluation.
•Radiology 2020;296:
e97-e104. doi.org/10.1148/radiol.2020201473
- Wise J. Covid-19:
T-cell response lasts for at least six months after infection,.BMJ.
2020;371:m4257. doi: 10.1136/bmj.m4257.
- Pradenas
E.,
Trinité
B.,
Urrea
V.,
Marfil
S.,
Ávila-Nieto
C.,
Rodríguez
de la Concepción ML. et al. Stable neutralizing antibody levels 6
months after mild and severe COVID-19 episodes. Med (N Y)
2020;2(3):313-320.e4. doi: 10.1016/j.medj.2021.01.005
- Jabal
KA.,
Ben-Amram
H.,
Beiruti
K.,
Batheesh
Y.,
Sussan
C.,
Zarka
S. et al. Impact of age, ethnicity, sex and prior infection status on
immunogenicity following a single dose of the BNT162b2 mRNA COVID-19
vaccine: real-world evidence from healthcare workers, Israel, December
2020 to January 2021.
Euro
Surveillance. 2021;26(6):pii=2100096.
doi.org/10.2807/1560-7917.ES.2021.26.6.2100096
- Krammer
F.,
Srivastava
K.,
Alshammary
H.,
Amoako
AA.,
Awawda
MH.,
Beach
KF., et al., Antibody responses in seropositive persons after a single
dose of SARS-CoV-2 mRNA vaccine. N Engl J Med. 2021b Mar 10. doi:
10.1056/NEJMc2101667
- Saadat S., Rikhtegaran-Tehrani Z., Logue J., Newman M., Frieman MB.,
Harris AD., et al. Single dose vaccination in healthcare workers
previously infected with SARS-CoV-2. MedRxiv [Preprint].2021.
doi.org/10.1101/2021.01.30.21250843
- Arvin
AM.,
Fink
K.,
Schmid
MA.,
Cathcart
A.,
Spreafico
R.,
Havenar-Daughton
C.,et al. A perspective on potential antibody-dependent enhancement of
SARS-CoV-2. Nature. 2020;584(7821):353-363. doi:
10.1038/s41586-020-2538-8.
- Pardi N, Hogan MJ, Porter FW, Weissman D.
mRNA vaccines- a new
era in vaccinology. Nat Rev Drug Discov. 2018;17(4):261-279. doi:
10.1038/nrd.2017.243
- Alber
AB.,
Suter
DM. Dynamics of protein synthesis and degradation through the cell
cycle.
Cell
Cycle. 2019; 18(8): 784–794.
doi: 10.1080/15384101.2019.1598725
- Volkov IL., Johansson M. Single-Molecule Tracking Approaches to
Protein Synthesis Kinetics in Living Cells. Biochemistry. 2019, 58, 1,
7–14.
doi.org/10.1021/acs.biochem.8b00917
- Netea MG, Joosten LA, Latz E, Mills KH, Natoli G, Stunnenberg HG, et
al. Trained immunity:
A program of innate immune memory in health and disease. Science.
2016;352(6284):aaf1098. doi: 10.1126/science.aaf1098.